Lantern Pharma Inc（LTRN）美股招股说明书 S-1（2026-06-12首版）（英文版）（32页）.pdf

1、S-1 1 forms-1.htm S-1 As filed with the Securities and Exchange Commission on June 12,2026 Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 Lantern Pharma Inc.(Exact name of registrant as specified i

2、n its charter)Delaware 2834 46-3973463(State or other jurisdiction ofIncorporation or organization)(Primary Standard IndustrialClassification Code Number)(IRS EmployerIdentification Number)1920 McKinney Avenue,7th FloorDallas,Texas 75201(972)277-1136(Address,including zip code,and telephone number,i

3、ncluding area code,of registrants principal executive offices)Panna Sharma,Chief Executive OfficerLantern Pharma Inc.1920 McKinney Avenue,7th FloorDallas,Texas 75201(972)277-1136(Name,address,including zip code,and telephone number,including area code,of agent for service)Copy to:Daniel K.Donahue,Es

4、q.Greenberg Traurig,LLP18565 Jamboree Road,Suite 500Irvine,California 92612(949)732-6500 Approximate date of commencement of proposed sale to the public:As soon as practicable after this RegistrationStatement becomes effective.If any of the securities being registered on this Form are to be offered

5、on a delayed or continuous basis pursuant to Rule 415under the Securities Act of 1933,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,pleasecheck the following box and list the Securities Act registration

6、 statement number of the earlier effective registration statement forthe same offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following box andlist the Securities Act registration statement number of the earlier effective registrati